Evidence map›Paper›PMID 28992183›Full record

ArticleJournal of molecular cell biology2017

ER stress-induced aggresome trafficking of HtrA1 protects against proteotoxicity.

Maximilian J Gerhardt, Joseph A Marsh, Margaux Morrison, Andrius Kazlauskas, Arogya Khadka, Stephan Rosenkranz, Margaret M DeAngelis, Magali Saint-Geniez, Sarah Melissa P Jacobo

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of molecular cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Maximilian J GerhardtDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Joseph A MarshMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
Margaux MorrisonDepartment of Ophthalmology and Visual Sciences, University of Utah and John A. Moran Eye Center, Salt Lake City, UT 84132, USA.
Andrius KazlauskasDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Arogya KhadkaDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Stephan RosenkranzDepartment III of Internal Medicine, Cologne University Heart Center, Center for Molecular Medicine, University of Cologne, 50931 Cologne, Germany.
Margaret M DeAngelisDepartment of Ophthalmology and Visual Sciences, University of Utah and John A. Moran Eye Center, Salt Lake City, UT 84132, USA.
Magali Saint-GeniezDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Sarah Melissa P JacoboDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Massachusetts Eye and Ear Infirmary · USUniversity of Utah · USInstitute of Genetics and Cancer · GBUniversity of Cologne · DE

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI PAUL STEVEN BERNSTEIN · 2005 to 2026
$14.6M
Vision Research Training Grant at the University of UtahT32EY024234 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI DAVID KRIZAJ, Monica L Vetter · 2014 to 2026
$2.3M
Medical Research Council MR/M02122X/1NEI NIH HHS P30 EY003790NEI NIH HHS P30 EY014800NEI NIH HHS T32 EY024234
6 · The paper itself

Abstract

High temperature requirement A1 (HtrA1) belongs to an ancient protein family that is linked to various human disorders. The precise role of exon 1-encoded N-terminal domains and how these influence the biological functions of human HtrA1 remain elusive. In this study, we traced the evolutionary origins of these N-terminal domains to a single gene fusion event in the most recent common ancestor of vertebrates. We hypothesized that human HtrA1 is implicated in unfolded protein response. In highly secretory cells of the retinal pigmented epithelia, endoplasmic reticulum (ER) stress upregulated HtrA1. HtrA1 co-localized with vimentin intermediate filaments in highly arborized fashion. Upon ER stress, HtrA1 tracked along intermediate filaments, which collapsed and bundled in an aggresome at the microtubule organizing center. Gene silencing of HtrA1 altered the schedule and amplitude of adaptive signaling and concomitantly resulted in apoptosis. Restoration of wild-type HtrA1, but not its protease inactive mutant, was necessary and sufficient to protect from apoptosis. A variant of HtrA1 that harbored exon 1 substitutions displayed reduced efficacy in rescuing cells from proteotoxicity. Our results illuminate the integration of HtrA1 in the toolkit of mammalian cells against protein misfolding and the implications of defects in HtrA1 in proteostasis.

Indexed as

Endoplasmic Reticulum StressCell LineEvolution, MolecularGene Knockdown TechniquesHumansIntermediate FilamentsMicrotubule-Organizing CenterPhylogenyProteasome Endopeptidase ComplexProtective AgentsProtein FoldingProteinsProtein TransportRetinal Pigment EpitheliumUbiquitinUnfolded Protein ResponseProteasome Endopeptidase ComplexProtective AgentsProteinsUbiquitinVimentin

Identifiers

PMID28992183
PMCPMC5823240
OpenAlexW2738355617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.